BMO Capital analyst Juan Sanabria initiated coverage of American Healthcare REIT (AHR) with an Outperform rating and $55 price target The company is well positioned to continue to deliver leading earnings growth driven by its Trilogy and senior housing exposure, the analyst tells investors in a research note. BMO believes American Healthcare has “robust” demand/supply fundamentals that are expected to accelerate.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- Closing Bell Movers: Texas Instruments up 8%, F5 up 11% on earnings
- American Healthcare REIT to replace Cadence Bank in S&P 400 at open on 2/2
- American Healthcare REIT price target lowered to $52 from $53 at Truist
- American Healthcare REIT Declares Q4 2025 Distribution
- American Healthcare REIT named ‘Top Pick’ for 2026 at Jefferies